27 related articles for article (PubMed ID: 11848529)
21. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
Lange PH; Brawer MK
Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
[No Abstract] [Full Text] [Related]
22. Prostate gland: anatomy, hyperplasia, cytologic atypia, adenocarcinoma, and tumor markers.
Gray JM
Prog Clin Biol Res; 1987; 237():15-29. PubMed ID: 3317426
[No Abstract] [Full Text] [Related]
23. Serum soluble Fas level for detection and staging of prostate cancer.
Furuya Y; Fuse H; Masai M
Anticancer Res; 2001; 21(5):3595-8. PubMed ID: 11848529
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
25. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
Hall MC; Roehrborn CG; McConnell JD
Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473
[TBL] [Abstract][Full Text] [Related]
26. Is prostate-specific antigen still the best tumor marker for prostate cancer?
Leewansangtong S; Soontrapa S; Tantiwong A
J Med Assoc Thai; 1999 Oct; 82(10):1034-40. PubMed ID: 10561969
[TBL] [Abstract][Full Text] [Related]
27. [PSA in the staging and monitoring of cancer of the prostate].
Gil Sanz MJ; Sanz Velez JI; Liedana Torres JM; Roncales Badal AL; Allepuz Losa C; Rioja Sanz LA
Actas Urol Esp; 1991; 15(6):527-31. PubMed ID: 1724347
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]